2 Jefferies Group Novartis AG Trades
Jefferies Group started to build up the position in Novartis AG in Q4 2023. Since then they sold 49.4 Thousand shares. The investor sold all their shares in Q1 2024 and doesn't own any shares in Novartis AG anymore.
News about Novartis AG - ADR and Jefferies Group
Novartis phase III data confirm sustained efficacy and long─term safety of oral remibrutinib in chronic spontaneous urticaria
… , and multiple sclerosis4-8. Novartis will submit remibrutinib for approval … effective oral option within the Novartis immunology portfolio, which current...
Sandoz Group: Novartis Spinoff With A Double-Digit EBITDA CAGR Through 2028
Sandoz is a global leader in the generics and biosimilars sector. Click here to read why I think spinning off SDZNY stock was a good move by Novartis.
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
LEIDEN, Netherlands , April 11, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commerci...
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS ...